Pfizer has asked the federal judge handling the multidistrict litigation alleging that its antidepressant drug Zoloft causes birth defects to limit a key plaintiffs expert’s testimony to the content of her report.
The plaintiffs responded that Pfizer had kept their expert, Dr. Anick Berard, from explaining her methods during deposition. The drug company now characterizes Berard’s method for citing to scientific studies as flawed, arguing that she “cherry-picked” studies and disregarded ones that didn’t support her proposition that Zoloft can cause birth defects in babies born to women who took the drug while pregnant.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
